Published in FEBS J on June 10, 2013
Errors in Crystal structure of HINT from Helicobacter pylori. Acta Crystallogr F Struct Biol Commun (2016) 1.07
Molecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease. Prog Biophys Mol Biol (2015) 0.81
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr (2011) 67.55
XDS. Acta Crystallogr D Biol Crystallogr (2010) 67.46
REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr (2011) 39.32
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol (2011) 28.61
A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res (2010) 11.42
Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr (2012) 11.31
Towards a knowledge-based Human Protein Atlas. Nat Biotechnol (2010) 11.05
The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature (2006) 2.86
The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases. EMBO J (2002) 2.46
Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry (2002) 2.42
A family of LIC vectors for high-throughput cloning and purification of proteins. Methods Mol Biol (2009) 2.30
Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science (1997) 2.27
Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins. Nat Struct Biol (1997) 1.96
Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet (2012) 1.85
Processing the message: structural insights into capping and decapping mRNA. Curr Opin Struct Biol (2005) 1.69
Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Proc Natl Acad Sci U S A (1998) 1.68
Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci U S A (1996) 1.41
Insights into the structure, mechanism, and regulation of scavenger mRNA decapping activity. Mol Cell (2004) 1.41
The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in FcepsilonRI-activated mast cells. Immunity (2004) 1.36
Functional analysis of mRNA scavenger decapping enzymes. RNA (2004) 1.35
The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem (2006) 1.32
Cancer and the FRA3B/FHIT fragile locus: it's a HIT. Br J Cancer (2003) 1.32
The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci (2005) 1.31
Three-dimensional structure of galactose-1-phosphate uridylyltransferase from Escherichia coli at 1.8 A resolution. Biochemistry (1995) 1.26
Structural switch of lysyl-tRNA synthetase between translation and transcription. Mol Cell (2012) 1.17
Lysyl-tRNA synthetase-generated lysyl-adenylate is a substrate for histidine triad nucleotide binding proteins. J Biol Chem (2006) 1.09
Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease. Nat Struct Mol Biol (2011) 1.01
Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FcepsilonRI-activated mast cells. Mol Cell Biol (2005) 0.97
Hit proteins, mitochondria and cancer. Biochim Biophys Acta (2011) 0.95
Structural analysis of the H166G site-directed mutant of galactose-1-phosphate uridylyltransferase complexed with either UDP-glucose or UDP-galactose: detailed description of the nucleotide sugar binding site. Biochemistry (1997) 0.92
Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function. Hepatology (2013) 0.91
Probing the impact of the echinT C-terminal domain on structure and catalysis. J Mol Biol (2010) 0.89
Conserved core substructures in the overlay of protein-ligand complexes. J Chem Inf Model (2011) 0.88
The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit. Biochemistry (2004) 0.87
Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients. Oncol Lett (2011) 0.83
Impact of the C-terminal loop of histidine triad nucleotide binding protein1 (Hint1) on substrate specificity. Biochemistry (2007) 0.82
Evidence that human histidine triad nucleotide binding protein 3 (Hint3) is a distinct branch of the histidine triad (HIT) superfamily. J Mol Biol (2007) 0.81
Kinetic mechanism of human histidine triad nucleotide binding protein 1. Biochemistry (2013) 0.79
HINT2 and fatty liver disease: mitochondrial protein hyperacetylation gives a hint? Hepatology (2013) 0.77
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Chemically controlled protein assembly: techniques and applications. Chem Rev (2010) 1.46
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening. Biochem Pharmacol (2004) 1.32
Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. Mol Pharm (2007) 1.22
31P NMR and genetic analysis establish hinT as the only Escherchia coli purine nucleoside phosphoramidase and as essential for growth under high salt conditions. J Biol Chem (2005) 1.12
Lysyl-tRNA synthetase-generated lysyl-adenylate is a substrate for histidine triad nucleotide binding proteins. J Biol Chem (2006) 1.09
Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis. Chem Biol (2011) 1.08
Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies. Biochemistry (2004) 1.08
A highly efficient catalyst for oxime ligation and hydrazone-oxime exchange suitable for bioconjugation. Bioconjug Chem (2013) 1.06
Engineered monomeric human histidine triad nucleotide-binding protein 1 hydrolyzes fluorogenic acyl-adenylate and lysyl-tRNA synthetase-generated lysyl-adenylate. J Biol Chem (2007) 1.06
Arylamine N-acetyltransferase I. Int J Biochem Cell Biol (2007) 1.01
Catalytic mechanism of hamster arylamine N-acetyltransferase 2. Biochemistry (2005) 1.00
Designing protein dimerizers: the importance of ligand conformational equilibria. J Am Chem Soc (2003) 1.00
Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. ACS Chem Biol (2009) 0.99
Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target. Med Res Rev (2012) 0.98
Chemically controlled self-assembly of protein nanorings. J Am Chem Soc (2006) 0.97
NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity. J Mol Biol (2006) 0.96
Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharm (2012) 0.96
Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. Eur J Med Chem (2009) 0.94
Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP. Bioorg Med Chem Lett (2005) 0.93
Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid. Bioorg Med Chem Lett (2005) 0.92
Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening. J Chem Inf Model (2009) 0.92
Dissociation of I domain and global conformational changes in LFA-1: refinement of small molecule-I domain structure-activity relationships. Biochemistry (2005) 0.91
Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis. J Am Chem Soc (2011) 0.90
Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation. J Mol Biol (2006) 0.90
Designing a pronucleotide stratagem: lessons from amino acid phosphoramidates of anticancer and antiviral pyrimidines. Mini Rev Med Chem (2004) 0.89
Self-assembly of antibodies by chemical induction. Angew Chem Int Ed Engl (2008) 0.89
Probing the impact of the echinT C-terminal domain on structure and catalysis. J Mol Biol (2010) 0.89
Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines. Chem Res Toxicol (2008) 0.88
Dihydrofolate reductase mutant with exceptional resistance to methotrexate but not to trimetrexate. J Med Chem (2003) 0.87
Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic. J Am Chem Soc (2010) 0.86
Simultaneous dual protein labeling using a triorthogonal reagent. J Am Chem Soc (2013) 0.86
Inhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazides. Chembiochem (2014) 0.86
Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors. J Med Chem (2014) 0.85
Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. Chem Res Toxicol (2007) 0.85
Enzyme nanorings. ACS Nano (2008) 0.85
Use of differential scanning fluorimetry to optimize the purification and crystallization of PLP-dependent enzymes. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.84
Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors. Biochim Biophys Acta (2010) 0.84
Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines. Chem Res Toxicol (2009) 0.84
Distinct translational control in CD4+ T cell subsets. PLoS Genet (2013) 0.84
Expression, purification and characterization of recombinant mouse translation initiation factor eIF4E as a dihydrofolate reductase (DHFR) fusion protein. Protein Expr Purif (2008) 0.83
Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1. Protein J (2005) 0.83
HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia. Neuropharmacology (2015) 0.83
Inhibitors of HCV NS5B polymerase. Part 2: Evaluation of the northern region of (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid. Bioorg Med Chem Lett (2005) 0.83
Impact of the C-terminal loop of histidine triad nucleotide binding protein1 (Hint1) on substrate specificity. Biochemistry (2007) 0.82
Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate. Pharm Res (2003) 0.82
Evidence that human histidine triad nucleotide binding protein 3 (Hint3) is a distinct branch of the histidine triad (HIT) superfamily. J Mol Biol (2007) 0.81
The structure of the TOG-like domain of Drosophila melanogaster Mast/Orbit. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.81
Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene. Chem Res Toxicol (2004) 0.80
Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring. Bioorg Med Chem Lett (2012) 0.80
Direct measurement of nucleoside monophosphate delivery from a phosphoramidate pronucleotide by stable isotope labeling and LC-ESI(-)-MS/MS. Mol Pharm (2005) 0.80
Irreversible inactivation of arylamine N-acetyltransferases in the presence of N-hydroxy-4-acetylaminobiphenyl: a comparison of human and hamster enzymes. Chem Res Toxicol (2005) 0.79
Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents. Protein J (2004) 0.79
Molecular Modeling of Geometries, Charge Distributions, and Binding Energies of Small, Drug-Like Molecules Containing Nitrogen Heterocycles and Exocyclic Amino Groups in the Gas Phase and Aqueous Solution. J Chem Theory Comput (2008) 0.79
Kinetic mechanism of human histidine triad nucleotide binding protein 1. Biochemistry (2013) 0.79
E. coli histidine triad nucleotide binding protein 1 (ecHinT) is a catalytic regulator of D-alanine dehydrogenase (DadA) activity in vivo. PLoS One (2011) 0.78
Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells. Invest New Drugs (2014) 0.78
Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats. Antimicrob Agents Chemother (2002) 0.78
Chemically self-assembled antibody nanostructures as potential drug carriers. Mol Pharm (2012) 0.77
Reversible re-programing of cell-cell interactions. Angew Chem Int Ed Engl (2014) 0.77
Programmable self-assembly of antibody-oligonucleotide conjugates as small molecule and protein carriers. J Am Chem Soc (2012) 0.77
Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190. FEBS J (2009) 0.77
Identification of the amino acid-AZT-phosphoramidase by affinity T7 phage display selection. Bioorg Med Chem Lett (2009) 0.77
Targeted delivery of antisense oligonucleotides by chemically self-assembled nanostructures. Mol Pharm (2013) 0.76
Arylamine N-acetyltransferases: covalent modification and inactivation of hamster NAT1 by bromoacetamido derivatives of aniline and 2-aminofluorene. J Protein Chem (2003) 0.76
Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemia. Cancer Biother Radiopharm (2006) 0.76
A method for quantitating the intracellular metabolism of AZT amino acid phosphoramidate pronucleotides by capillary high-performance liquid chromatography-electrospray ionization mass spectrometry. Mol Pharm (2005) 0.76
Monitoring the intracellular metabolism of nucleoside phosphoramidate pronucleotides by 31P NMR. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
Synthesis and evaluation of potential inhibitors of human and Escherichia coli histidine triad nucleotide binding proteins. Bioorg Med Chem Lett (2011) 0.75
A Crystal Structure-Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides. Mol Pharm (2017) 0.75
Structure-Based Optimization of Pyridoxal 5'-Phosphate (PLP)-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis. J Med Chem (2017) 0.75
Searching for likeness in a database of macromolecular complexes. J Chem Inf Model (2013) 0.75
Synthesis of amino acid phosphoramidate monoesters via H-phosphonate intermediates. Curr Protoc Nucleic Acid Chem (2006) 0.75
Anti-EGFR Fibronectin Bispecific Chemically Self-Assembling Nanorings (CSANs) Induce Potent T-cell Mediated Anti-Tumor Response and Downregulation of EGFR Signaling and PD-1/PD-L1 Expression. J Med Chem (2020) 0.75
A dogma in need of a reformation. Mol Pharm (2005) 0.75
Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma. J Med Chem (2017) 0.75
Chemically induced self-assembly of enzyme nanorings. Methods Mol Biol (2011) 0.75
Protein interface remodeling in a chemically induced protein dimer. J Mol Recognit (2012) 0.75
Molecular Modeling of Geometries, Charge Distributions, and Binding Energies of Small, Druglike Molecules Containing Nitrogen Heterocycles and Exocyclic Amino Groups in the Gas Phase and Aqueous Solution. J Chem Theory Comput (2009) 0.75